Lataa...
Nalfurafine Suppresses Pruritogen- and Touch-evoked Scratching Behavior in Models of Acute and Chronic Itch in Mice
The kappa-opioid agonist, nalfurafine, has been approved in Japan for treatment of itch in patients with chronic kidney disease. We presently investigated if systemic administration of nalfurafine inhibited ongoing or touch-evoked scratching behavior (alloknesis) following acute intradermal injectio...
Tallennettuna:
| Julkaisussa: | Acta Derm Venereol |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5550099/ https://ncbi.nlm.nih.gov/pubmed/24890341 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2340/00015555-1879 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|